| Rite Aid Pharmacy 06488 | |
| 105 Washington Ave N, Kent, Washington 98032 | |
| (253) 373-0156 |
| Name | Rite Aid Pharmacy 06488 |
|---|---|
| Organization Name | Thrifty Payless Inc |
| Location | 105 Washington Ave N, Kent, Washington 98032 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (253) 373-0156 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received orphan drug designation from both the European Medicines Agency EMEA and the US Food and Drug Administration FDA for its investigational drug trabedersen in the treatment of pancreatic carcinoma.
A study performed by researchers at the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) from the Spanish National Research Council (CSIC) in collaboration with Stony Brook University (USA) proposes a new strategy for the development of new drugs based on the inhibition of tyrosine kinase enzymes, molecules that activate and trigger many cellular processes. The results have been published in the Chemistry - A European Journal.
Given the competing factors of America's growing international interests and shrinking resources to engage on the global arena, the federal government must take a more critical look at how best to deliver accountable, transparent, and sustainable development aid to countries in need and ask itself how best to support our national security, economic, and humanitarian goals.
President Obama and Democrats are scrambling to find a way to pay for the specifics that he laid out in his speech Wednesday night, and they are pushing for a trigger that would rein in spending if cost containment for health care reform isn't met.
› Verified 2 days ago
| NPI Number | 1821268699 |
| Organization Name | THRIFTY PAYLESS INC |
| Doing Business As | RITE AID PHARMACY 06488 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 105 Washington Avenue North, Kent, WA 98032 |
| Phone Number | 253-373-0156 |
News Archive
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received orphan drug designation from both the European Medicines Agency EMEA and the US Food and Drug Administration FDA for its investigational drug trabedersen in the treatment of pancreatic carcinoma.
A study performed by researchers at the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) from the Spanish National Research Council (CSIC) in collaboration with Stony Brook University (USA) proposes a new strategy for the development of new drugs based on the inhibition of tyrosine kinase enzymes, molecules that activate and trigger many cellular processes. The results have been published in the Chemistry - A European Journal.
Given the competing factors of America's growing international interests and shrinking resources to engage on the global arena, the federal government must take a more critical look at how best to deliver accountable, transparent, and sustainable development aid to countries in need and ask itself how best to support our national security, economic, and humanitarian goals.
President Obama and Democrats are scrambling to find a way to pay for the specifics that he laid out in his speech Wednesday night, and they are pushing for a trigger that would rein in spending if cost containment for health care reform isn't met.
› Verified 2 days ago
News Archive
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received orphan drug designation from both the European Medicines Agency EMEA and the US Food and Drug Administration FDA for its investigational drug trabedersen in the treatment of pancreatic carcinoma.
A study performed by researchers at the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) from the Spanish National Research Council (CSIC) in collaboration with Stony Brook University (USA) proposes a new strategy for the development of new drugs based on the inhibition of tyrosine kinase enzymes, molecules that activate and trigger many cellular processes. The results have been published in the Chemistry - A European Journal.
Given the competing factors of America's growing international interests and shrinking resources to engage on the global arena, the federal government must take a more critical look at how best to deliver accountable, transparent, and sustainable development aid to countries in need and ask itself how best to support our national security, economic, and humanitarian goals.
President Obama and Democrats are scrambling to find a way to pay for the specifics that he laid out in his speech Wednesday night, and they are pushing for a trigger that would rein in spending if cost containment for health care reform isn't met.
› Verified 2 days ago
Accredo Health Group Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 22623 68th Ave S, Kent, Washington 98032 Phone: (253) 872-2121 | |
Breg, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 25528 74th Ave S, Kent, Washington 98032 Phone: (253) 859-7791 | |
Fred Meyer Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 16735 Se 272nd Street, Kent, Washington 98042 Phone: (253) 639-7433 | |
Fred Meyer Pharmacy #172 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 10201se240th St, Kent, Washington 98031 Phone: (253) 859-5533 | |
Fred Meyer Pharmacy #215 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 25250 Pacific Hwy S, Kent, Washington 98032 Phone: (253) 946-7433 |